Alan Attie
16Patents
3h-index
27Co-inventors
60Inventor score
Filing activity: Jun 4, 1991 → Feb 13, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5521071A | Soluble LDL receptor and gene | Human Necessities | 8 | Expired |
| US7790408B1 | Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents | Physics | 7 | Active |
| US5472858A | Production of recombinant proteins in insect larvae | Chemistry; Metallurgy | 3 | Expired |
| US6987001B2 | Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents | Physics | 3 | Expired |
| US9738697B2 | Alpha/beta-polypeptide analogs of glucagon-like peptide-1 | Human Necessities | 2 | Active |
| US10376563B1 | Methods for systemically delivering polypeptides and microorganisms therefor | Chemistry; Metallurgy | 2 | Active |
| US7166584B1 | Cholesterol transport gene | Physics | 1 | Expired |
| US8507557B2 | Potentiators of insulin secretion | Physics | 0 | Active |
| US10723779B2 | Alpha/beta-polypeptide analogs of glucagon-like peptide 1 | Human Necessities | 0 | Active |
| US9381176B2 | E-prostanoid receptor, Ptger3, as a novel anti-diabetic therapeutic target | Human Necessities | 0 | Active |
| US7696151B2 | Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents | Physics | 0 | Active |
| US7863301B2 | Potentiators of insulin secretion | Physics | 0 | Expired |
| US7816075B2 | Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents | Physics | 0 | Active |
| US7442500B2 | Methods of diagnosing susceptibility to obesity | Chemistry; Metallurgy | 0 | Expired |
| US7517860B1 | Inhibition of lipoprotein secretion | Chemistry; Metallurgy | 0 | Expired |
| US11427569B2 | Benzoimidazole indolyl methanes and methods of using them to inhibit PCKS9 and PCKS9-mediated ailments | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.